PEREGRINE CAPITAL MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:
$9.10M
portfolio value
PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.11% | -5.57K shares | 205K | $106.21 | 85.73K |
| Q2 2022 | share | Decrease | -0.08% | -72 shares | 334K | $97.48 | 91.31K |
| Q1 2022 | share | Decrease | -6.69% | -6.55K shares | 226K | $93.75 | 91.38K |
| Q4 2021 | share | Increase | 0.00% | 97.93K shares | 8.34M | $84.63 | 97.93K |